Myxedema-associated cardiogenic shock treated with intravenous triiodothyronine.
MacKerrow
S D
SD
University of New Mexico, Albuquerque.
Osborn
L A
LA
Levy
H
H
Eaton
R P
RP
Economou
P
P
D000284:Administration, Oral; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D009230:Myxedema / Q000150:complications* / Q000188:drug therapy; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology*; D013974:Thyroxine / Q000627:therapeutic use; D014284:Triiodothyronine / Q000008:administration & dosage / Q000627:therapeutic use*
D014284:Triiodothyronine; D013974:Thyroxine